Has Milton Little, MD received payments from drug or device companies?

Yes. Drug and device makers reported $243,868 in general payments to Milton Little, MD across 253 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Milton Little, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Milton Little, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Milton Little, MD

Orthopaedic Surgery · Los Angeles, CANPI 1407015092

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Globus Medical at 35.1% of the total. Reporting peaked in 2024 at $64,594 and has fallen 55.4% since, to $28,806 in 2025. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$243,868in general payments, 2019–2025

Across 253 payments — averaging $963.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Globus Medical$86K
Medical Device Business Services, Inc.$52K
Synthes GmbH$47K
Stryker$26K
Synthes USA Products LLC$17K
Restor3d, Inc.$12K
plus $4K from 12 others

What the payments were for

Consulting fees$119,86449%
Speaking & faculty fees$74,54831%
Travel & lodging$38,39316%
Food & beverage$7,3333%
Ownership interest$3,7312%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Globus Medical	50	$85,559
Medical Device Business Services, Inc.	43	$51,590
Synthes GmbH	51	$47,002
Stryker	56	$25,813
Synthes USA Products LLC	13	$17,379
Restor3d, Inc.	8	$12,461
Zimmer Biomet	4	$1,878
Johnson & Johnson	12	$709
My01 Inc.	2	$364
Si-bone, Inc.	2	$317
Acumed LLC	4	$212
Joint Restoration Foundation, Inc.	1	$188
Micromed Inc	1	$142
Nuvasive Specialized Orthopedics, Inc.	1	$141
Bioventus LLC	1	$38
Dynasplint Systems Inc.	2	$36
Aroa Biosurgery Incorporated	1	$22
ERMI LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Distal Humerus Fracture System$31,098
NA$27,947
PANGEA$19,527
Ankle Fracture System$9,788
IM NAILS$6,283
Clavical Fixation (16-186)$5,448
Clavicle Fixation$5,400
Anthem$4,613
PRO$3,568
Prox Hum$2,700
Proximal Humerus Strut$2,577
VA-LCP$1,615
Periprosthetic Fracture$886
EX NAILS$573
Proximal Humerus Plate$563
T2$522
GAMMA$491
MY01 Continuous Compartmental Pressure Monitor$364
Small Frag Plating System$355
HOFFMANN$353

How this compares

$243,868 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024

$197,168

Medicare patients

335

Services billed

763

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	17	$93
Meloxicam	14	$34
Tramadol Hcl	15	$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Los Angeles

Kelly VinceLos Angeles$9.6M
Jay LiebermanLos Angeles$4.8M
Thomas SchmalzriedLos Angeles$4M
David SkaggsLos Angeles$2.6M
David ThordarsonLos Angeles$2.5M
Edward McPhersonLos Angeles$1.2M
Daniel AllisonLos Angeles$1.1M
Justin SalimanLos Angeles$912K
Charles MoonLos Angeles$760K
Andrew SpitzerLos Angeles$738K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →